• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Meetings
    • 2027 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2026 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2026 Proffered Presentations

2026 Proffered Presentations

 

← Back to Previous Page

 

S237: QUALITY OF LIFE OUTCOMES FOLLOWING STYLOIDECTOMY/C1 OSTECTOMY IN PATIENTS WITH EXTRACRANIAL VENOUS OUTFLOW OBSTRUCTION
Alisha E Suri, BSc1; Katherine Koch, BFA1; Trevor H Torigoe, PhD1; Edward J Hepworth, MD2; Jared Theler, MD3; David Young, MD3; Ferdinand K Hui, MD3; 1John A. Burns School of Medicine, University of Hawaii; 2Denver Sinus Care; 3The Queen's Health Systems

Introduction: Idiopathic intracranial hypertension (IIH) is characterized by inexpicably elevated intracranial pressure. Hallmark symptoms include headache, pulsatile tinnitus, transient visual obscurations, and papilledema. While traditional treatments include weight loss, acetazolamide, CSF diversion, and venous sinus stenting, focus is shifting toward addressing extracranial venous outflow obstruction. As the internal jugular veins (IJVs) are commonly affected, surgical resection of impinging structures, such as the styloid process and C1 transverse process, is becoming more popular. This study is among the first to report on objective patient-centred outcomes after styloidectomy/C1 ostectomy. 

Methods: A retrospective chart review was performed at a single site. Patients were included if they underwent unilateral styloidectomy/C1 ostectomy and completed the following standardized instruments immediately post-operatively and 3 months post-operatively: Cerebral Venous Disease Symptom Score (CVDSS), Headache Impact Test (HIT-6), 12-item Short Form Survey (SF-12), and Quick Dementia Rating System (QDRS). Descriptive statistics and non-parametric tests were used to summarize data. Visual evaluation of pre- and post-operative computed tomography venogram (CTV) was performed to determine whether IJV patency improved postoperatively.

Results: 13 patients (92.3% F) met inclusion criteria. Median age was 46 (33, 55) years, BMI was 25.5 (21.6, 29.4) kg/m2, and duration of IIH symptomatology was 9 (5.5, 12) years. Median pre-operative CVDSS score was 15 (14, 19), which improved to 8 (3, 13) post-operatively (Wilcoxon p=0.007) while HIT-6 scores improved from 32 (24, 35) to 19 (7, 26) (Wilcoxon p=0.04, Cohen's d=1.2) (Figure 1). Median SF-12 Mental Component Score (MCS) increased from 26.9 (20.6, 29.4) to 36.5 (30.0, 46.9) (Wilcoxon p=0.01, Cohen's d=-1.3), and Physical Component Score (PCS) increased from 26.8 (24.0, 30.2) to 35.3 (32.3, 43.0) (Wilcoxon p=0.01, Cohen's d=-1.2) (Figure 2). Median cognitive QDRS subscore decreased from 2.5 (0.6, 3.5) to 0.3 (0, 2.5) (Wilcoxon p=0.1, Cohen's d=0.7), behavioral QDRS subscore decreased from 5.8 (4.0, 6.9) to 0.8 (0.5, 4.4) (p=0.03, Cohen's d=1.0), and total QDRS score decreased from 8.8 (4.4, 10.4) to 2.3 (0.6, 5.0) (Wilcoxon p=0.02, Cohen's d=1.0) (Figure 3). All patients demonstrated a visible improvement in IJV patency on CTV postoperatively (Figure 4).

Figure 1 –  Change in CVDSS and HIT-6 scores after styloidectomy/C1 ostectomy. 

Figure 2 – Change in SF-12 mental (MCS-12) and physical (PSC-12) scores after styloidectomy/C1 ostectomy. 

Figure 3 – Change in QDRS cognitive, behavioral, and total scores after styloidectomy/C1 ostectomy. 

Figure 4 – Axial CTVs of a characteristic C1 ostectomy/styloidectomy patient immediately pre- and post-operatively. (A) Pre-operative CTV showing right IJV compressed between styloid process (red arrow) and C1 transverse process (black arrows). (B) Post-operative CTV showing patent right IJV (blue arrow) without osteological compressions due to resected styloid and C1 transverse process (black arrow).

Conclusion: Given the strong observed effect sizes, styloidectomy/C1 ostectomy may be associated with significant, multi-domain quality of life improvement with respect to headaches, physical and mental well-being, cognition, and behavior in those afflicted with IIH due to extracranial venous outflow obstruction. These findings support further exploration of this surgical intervention, ideally in larger prospective studies. 

 

← Back to Previous Page

Copyright © 2026 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved